Expert Opinion on Drug Discovery
Editor-in-Chief required
Deadline 07 August 2026
About the role
Expert Opinion on Drug Discovery is seeking a dedicated and accomplished scholar specializing in the drug discovery process to join as Editor-in-Chief.
This is an opportunity to expand your portfolio of skills working alongside our expert editorial team. You will drive the success of this internationally recognized journal and establish yourself further as a thought leader in the field of drug discovery.
As Editor-in-Chief, you will also be the presiding expert on editorial matters pertaining to drug discovery. You will also work alongside the Commissioning Editor and Publisher to:
- Act as a figurehead, representing and promoting the journal within your community, at conferences, and at society events.
- Contribute your knowledge and expert perspective to journal development strategy and implementation.
- Leverage your professional network to attract high-quality submissions and identify emerging trends in drug discovery.
- Uphold Taylor & Francis’ commitment to scientific integrity and ethical publishing practices.
In return this position offers:
- International exposure, and recognition as a thought leader.
- Opportunities for professional development and networking for you and your team.
About the journal
Expert Opinion on Drug Discovery (1746-0441; 1746-045X) is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles in drug discovery.
Expert Opinion on Drug Discovery publishes original research and review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimization at the preclinical level.
Articles focus on the following key areas:
- Chemoinformatics
- Bioinformatics
- Assay development
- Novel screening technologies
- In vitro/in vivo models
- Structure-based drug design
- Systems biology
The journal also publishes drug case histories examining the steps involved in the preclinical and clinical development of a particular drug.
Please note that the journal does not publish case reports or case series.
Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;
Article Highlights – an executive summary of the author’s most critical points.
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
Reach an international clinical and medical audience alongside other key opinion leaders in your field by publishing with Expert Opinion on Drug Discovery, part of the Expert Collection brand.
Authors can choose to publish gold open access in this journal.
For any pre-submissions enquiries, please contact the Commissioning Editor.
Key Skills and Attributes
We are looking for a candidate who:
- Is a recognized leader in drug discovery with strong ties to the pharmaceutical industry and/or clinical trials.
- Actively participates in conferences, events, and digital platforms to promote the journal.
- Has significant experience in academic publishing, including editorial roles and peer review.
- Demonstrates a strong commitment to ethical publishing standards (COPE and ICMJE).
- Has the vision and enthusiasm to drive the journal’s development and growth.
- Can lead and engage a large editorial board, ensuring comprehensive coverage of the journal’s scope.
- Is willing to co-chair editorial board meetings every 6-12 months.
Application instructions
Submit your CV, cover letter (500-word max), and a vision statement (500-word max) via the application button.
For inquiries, contact Liam Francois-Hobbins, Publisher, at [email protected].
Apply for the role by filling in our formJournal pledge
The journal is committed to ensuring diversity, equity and inclusion within its editorial team and decision making processes. All applications will be treated as strictly confidential, and each will be judged on its merits without bias for seniority of institutional affiliation. We do not discriminate on the basis of race, colour, ancestry, national origin, religion, or religious creed, mental or physical disability, medical condition, genetic information, sex (including pregnancy, childbirth, and related medical conditions), sexual orientation, gender identity, gender expression, age, marital status, military or protected veteran status, citizenship, or other protected characteristics.
Did you know
Joining a Taylor & Francis journal as an Editor or Board member brings many personal and professional benefits.
Find more roles in your subject area with our Editor Recruitment search tool.